Shanghai ZJ Bio-Tech Co., Ltd (SHA:688317)
China · Delayed Price · Currency is CNY 20.93
-0.11 (-0.52%)
Feb 13, 2026, 3:00 PM CST
Shanghai ZJ Bio-Tech Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -143.83 | -127.46 | -136.86 | 760.27 | 758.52 | 932.01 |
Depreciation & Amortization | 67.71 | 67.71 | 66.69 | 60.24 | 24.84 | 19.68 |
Other Amortization | 1.42 | 1.42 | 0.59 | 0.08 | - | - |
Loss (Gain) From Sale of Assets | -0.04 | -0.04 | - | -0.03 | - | - |
Asset Writedown & Restructuring Costs | 22.53 | 22.53 | 1.15 | 0.59 | 0.03 | 0.27 |
Loss (Gain) From Sale of Investments | -0.06 | -0.06 | - | - | - | - |
Provision & Write-off of Bad Debts | 8.41 | 8.41 | 1.36 | 6.35 | 5.38 | 7.47 |
Other Operating Activities | 140.84 | 134.73 | 169.99 | -62.76 | 28.33 | 26.94 |
Change in Accounts Receivable | 37.31 | 37.31 | 114.77 | 12.17 | -25.19 | -122.29 |
Change in Inventory | 36.37 | 36.37 | 31.72 | -297.19 | -172.51 | -90.94 |
Change in Accounts Payable | -81.05 | -81.05 | -304.21 | 104.49 | 16.72 | 346.87 |
Change in Other Net Operating Assets | 0.98 | 0.98 | 0.61 | 1.18 | 5.86 | 26.25 |
Operating Cash Flow | 67.33 | 77.59 | -81.88 | 584.97 | 641.94 | 1,142 |
Operating Cash Flow Growth | -36.65% | - | - | -8.87% | -43.78% | 1389.41% |
Capital Expenditures | 0.21 | -19.49 | -81.15 | -74.56 | -498.06 | -74.58 |
Sale of Property, Plant & Equipment | -1.87 | 0.01 | 1.14 | 0.06 | - | 0.06 |
Investment in Securities | -316.45 | 0.06 | 2.32 | -1.53 | -21 | -12 |
Other Investing Activities | - | - | - | - | - | 0.21 |
Investing Cash Flow | -318.11 | -19.42 | -77.69 | -76.02 | -519.06 | -86.3 |
Long-Term Debt Repaid | - | -2.51 | -3.65 | -3.75 | - | - |
Net Debt Issued (Repaid) | 193.51 | -2.51 | -3.65 | -3.75 | - | - |
Issuance of Common Stock | - | - | - | - | 1,959 | - |
Repurchase of Common Stock | -35.33 | -35.33 | - | -102.03 | - | - |
Common Dividends Paid | -22.72 | -20.88 | -230.74 | -265.62 | -311.53 | -65.71 |
Dividends Paid | -22.72 | -20.88 | -230.74 | -265.62 | -311.53 | -65.71 |
Other Financing Activities | -184.55 | - | - | - | -19.3 | -2.79 |
Financing Cash Flow | -49.09 | -58.72 | -234.39 | -371.4 | 1,628 | -68.5 |
Foreign Exchange Rate Adjustments | 15.7 | 14.44 | 15.77 | 74.35 | -19.82 | -28.35 |
Net Cash Flow | -284.17 | 13.89 | -378.19 | 211.9 | 1,731 | 958.64 |
Free Cash Flow | 67.55 | 58.1 | -163.03 | 510.41 | 143.88 | 1,067 |
Free Cash Flow Growth | 30.13% | - | - | 254.76% | -86.52% | 1909.69% |
Free Cash Flow Margin | 51.37% | 32.52% | -59.43% | 21.94% | 7.13% | 52.01% |
Free Cash Flow Per Share | 0.36 | 0.30 | -0.85 | 2.64 | 0.76 | 7.31 |
Cash Income Tax Paid | 14.24 | 17.21 | 52.97 | 188.93 | 261.3 | 179.99 |
Levered Free Cash Flow | 67.44 | 42.13 | -98.85 | 410.82 | -144.71 | 759.52 |
Unlevered Free Cash Flow | 68.81 | 42.35 | -98.63 | 411.11 | -144.71 | 759.52 |
Change in Working Capital | -29.64 | -29.64 | -184.81 | -179.76 | -175.17 | 155.43 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.